Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OSIMERTINIB Cause Hypersensitivity? 57 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Hypersensitivity have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.2% of all adverse event reports for OSIMERTINIB.

57
Reports of Hypersensitivity with OSIMERTINIB
0.2%
of all OSIMERTINIB reports
4
Deaths
20
Hospitalizations

How Dangerous Is Hypersensitivity From OSIMERTINIB?

Of the 57 reports, 4 (7.0%) resulted in death, 20 (35.1%) required hospitalization, and 7 (12.3%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does OSIMERTINIB Cause?

Death (10,423) Malignant neoplasm progression (2,920) Diarrhoea (1,408) Drug resistance (1,026) Fatigue (819) Rash (772) Decreased appetite (706) Drug ineffective (627) Dyspnoea (621) Nausea (610)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which OSIMERTINIB Alternatives Have Lower Hypersensitivity Risk?

OSIMERTINIB vs OSPEMIFENE OSIMERTINIB vs OSPHENA OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB OSIMERTINIB vs OXACILLIN OSIMERTINIB vs OXALIPLATIN

Related Pages

OSIMERTINIB Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity OSIMERTINIB Demographics